Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display. (Q36023082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

review article

1 reference

title

Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Philipp Kuhn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Viola Fühner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Tobias Unkauf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gustavo Marcal Schmidt Garcia Moreira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

André Frenzel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sebastian Miethe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

21 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

Proteomics - Clinical Applications

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

9-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

922-948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

A roadmap to generate renewable protein binders to the human proteome

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Marketed therapeutic antibodies compendium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Production of fully human antibodies by transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human antibodies from transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development trends for human monoclonal antibody therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Accessing the human repertoire for broadly neutralizing HIV antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A surface expression vector for antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Making antibody fragments using phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Phage antibodies: filamentous phage displaying antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A human scFv antibody generation pipeline for proteome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Application of phage display to high throughput antibody generation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Domain antibodies: proteins for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single chain Fab (scFab) fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Camelid immunoglobulins and nanobody technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Serogroup-reactive and type-specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Methodology for selection of human antibodies to membrane proteins from a phage-display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

High-throughput screening of single-chain antibodies using multiplexed flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generating recombinant antibodies to the complete human proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Recombinant human monoclonal antibodies to Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation and analysis of the improved human HAL9/10 antibody phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Antibody arrays for high-throughput screening of antibody-antigen interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Which are the antibodies to watch in 2013?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The therapeutic monoclonal antibody market

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

CD3-specific antibodies: a portal to the treatment of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development and implementation of a single-chain Fv antibody for specific detection of Bacillus anthracis spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Detecting non-typhoid Salmonella in humans by ELISAs: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Real-time PCR as a diagnostic tool for bacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Sample preparation: the forgotten beginning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Nimotuzumab and cetuximab block ligand-independent EGF receptor signaling efficiently at different concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Rugged single domain antibody detection elements for Bacillus anthracis spores and vegetative cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of Lawsonia intracellularis specific single-chain Fv antibody fragments from phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Using phage display selected antibodies to dissect microbiomes for complete de novo genome sequencing of low abundance microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Is Mycobacterium tuberculosis a closer relative to Gram-positive or Gram-negative bacterial pathogens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Microbial complexes in subgingival plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The role of gingipains in the pathogenesis of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The Salmonella enterica pan-genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection of phage-displayed human antibody fragments on Dengue virus particles captured by a monoclonal antibody: application to the four serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human monoclonal single-chain antibodies specific to dengue virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human-like antibodies neutralizing Western equine encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Production of recombinant scFv against p24 of human immunodeficiency virus type 1 by phage display technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Cucumber mosaic cucumovirus antibodies from a synthetic phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation and characterization of a recombinant antibody fragment that binds to the coat protein of grapevine leafroll-associated virus 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection and characterization of single-chain recombinant antibodies against infectious haematopoietic necrosis virus from mouse phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The neutralizing human recombinant antibodies to pathogenic Orthopoxviruses derived from a phage display immune library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Novel phage display-derived H5N1-specific scFvs with potential use in rapid avian flu diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification and molecular characterization of human antibody fragments specific for dengue NS5 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Smallpox as a Biological Weapon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

High affinity human antibody fragments to dengue virus non-structural protein 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Venezuelan equine encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Continuing challenges in influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Influenza virus hemagglutinin stalk-based antibodies and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The role of vaccination in rabies prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The prevention and management of rabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of specific scFv antibodies to detect neurocysticercosis antigens and potential applications in immunodiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single-chain variable fragment antibodies selected by phage display against the sporozoite surface antigen P23 Of Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single chain variable fragment antibodies selected by phage display against the sporozoite surface antigen S16 of Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A combined phage display ScFv library against Myxobolus rotundus infecting crucian carp, Carassius auratus auratus (L.), in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Detection of Babesia gibsoni by reaction of phage display single chain antibodies with P50 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation and characterization of the human monoclonal antibodies C10 in single-chain fragment variable (scFv) format to glucose oxidase from Aspergillus niger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation of a highly reactive chicken-derived single-chain variable fragment against Fusarium verticillioides by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation, expression and characterization of two single-chain variable fragment antibodies against an endo-polygalacturonase secreted by Sclerotinia sclerotiorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation from phage display libraries of single chain variable fragment antibodies that recognize conformational epitopes in the malaria vaccine candidate, apical membrane antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Patients at high risk of invasive fungal infections: when and how to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

21 January 2018

Mosquito-borne Diseases

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Challenges in Antimalarial Drug Treatment for Vivax Malaria Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Antibodies for biodefense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation of a recombinant full-length human antibody binding to botulinum neurotoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of antiricin single domain antibodies toward detection and therapeutic reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Anthrax lethal and edema toxins in anthrax pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Anthrax as a biological weapon, 2002: updated recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Raxibacumab: potential role in the treatment of inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification and characterization of two novel staphylococcal enterotoxins, types S and T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation of Fab Fragment-Like Molecular Recognition Proteins against Staphylococcal Enterotoxin B by Phage Display Technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Modification of Na channel gating by an alpha scorpion toxin from Tityus serrulatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Scorpion toxins from Centruroides noxius and Tityus serrulatus. Primary structures and sequence comparison by metric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human ScFv that block sodium ion channel activity of tetrodotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Phage-display antibody detection of Chlamydia trachomatis-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of high-affinity single-chain antibodies against Mycobacterium avium subsp. paratuberculosis surface proteins from sheep with Johne's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of recombinant antibodies (scFvs) to grapevine virus B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Neutralizing human Fab fragments against measles virus recovered by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of human single-chain antibodies with broad reactivity for noroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

The analysis of VH and VL genes repertoires of Fab library built from peripheral B cells of human rabies virus vaccinated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single domain antibody multimers confer protection against rabies infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single-chain variable fragment (scFv) antibodies against rotavirus NSP4 enterotoxin generated by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection of single-chain antibodies against the VP8* subunit of rotavirus VP4 outer capsid protein and their expression in Lactobacillus casei

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Chicken single-chain variable fragments against the SARS-CoV spike protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Identification of a WSSV neutralizing scFv antibody by phage display technology and in vitro screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A phage-displayed chicken single-chain antibody fused to alkaline phosphatase detects Fusarium pathogens and their presence in cereal grains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Structural and functional characterization of a novel scFv anti-HSP60 of Strongyloides sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Isolation of single chain variable fragment (scFv) specific for Cry1C toxin from human single fold scFv libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: minimising venom toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A V H H that neutralizes the zinc metalloproteinase activity of botulinum neurotoxin type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Phage-display derived single-chain fragment variable (scFv) antibodies recognizing conformational epitopes of Escherichia coli heat-labile enterotoxin B-subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Production of a single-chain variable fragment antibody against fumonisin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction of a single chain variable fragment antibody (scFv) against tetrodotoxin (TTX) and its interaction with TTX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

A human single-chain variable fragment targeting to Vibrio vulnificus RtxA toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Development of Specific Recombinant Monoclonal Antibodies Against the Lipopolysaccharide of Ralstonia solanacearum Race 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Construction of human antibody gene libraries and selection of antibodies by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201600002

Human Fab fragments specific for the Haemophilus influenzae b polysaccharide isolated from a bacteriophage combinatorial library use variable region gene combinations and express an idiotype that mirrors in vivo expression

21 January 2018

1 reference

12 December 2020

Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein

1 reference

12 December 2020

Venezuelan equine encephalitis

1 reference

12 December 2020

Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms

1 reference

12 December 2020

Ebola virus can be effectively neutralized by antibody produced in natural human infection

1 reference

12 December 2020

Genetically engineered single-chain Fvs of human immunoglobulin against hepatitis C virus nucleocapsid protein derived from universal phage display library

1 reference

12 December 2020

Single domain camel antibodies: current status.

1 reference

12 December 2020

Chicken scFvs and bivalent scFv-C(H) fusions directed against HSP65 of Mycobacterium bovis

1 reference

12 December 2020

Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria

1 reference

12 December 2020

SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.

1 reference

12 December 2020

High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires

1 reference

12 December 2020

Detection and quantification of microcystins (cyanobacterial hepatotoxins) with recombinant antibody fragments isolated from a naïve human phage display library.

1 reference

12 December 2020

Improving the characteristics of a mycobacterial 16 kDa-specific chicken scFv

1 reference

12 December 2020

Recombinant full-size human antibody to Ebola virus

1 reference

12 December 2020

Single-chain antibody fragments from a display library derived from chickens immunized with a mixture of parasite and viral antigens

1 reference

12 December 2020

Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque

1 reference

12 December 2020

Biological characterization of human monoclonal antibodies to rabies virus

1 reference

12 December 2020

Monoclonal antibody therapy of cancer

1 reference

12 December 2020

The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

1 reference

12 December 2020

Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.

1 reference

12 December 2020

A family of cross-reacting proteins secreted by Mycobacterium tuberculosis

1 reference

12 December 2020

Pulmonary aspergillosis: a spectrum of disease.

1 reference

12 December 2020

Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.

1 reference

12 December 2020

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

12 December 2020

Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.

1 reference

12 December 2020

Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR

1 reference

12 December 2020

Single chain antibody fragment with serine protease inhibitory property capable of neutralizing toxicity of Trimeresurus mucrosquamatus venom

1 reference

12 December 2020

Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes

1 reference

12 December 2020

Aspergillus fumigatus and aspergillosis

1 reference

12 December 2020

Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.

1 reference

12 December 2020

The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis

1 reference

12 December 2020

Chicken immunoglobulin gamma-heavy chains: limited VH gene repertoire, combinatorial diversification by D gene segments and evolution of the heavy chain locus

1 reference

12 December 2020

Mechanism of cell entry and toxicity of an affinity- purified lectin from Ricinus communis and its differential effects on normal and virus-transformed fibroblasts

1 reference

12 December 2020

Identifiers

DOI

10.1002/PRCA.201600002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27198131%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference